At Monday’s annual general meeting (AGM), Charles Spicer, the chairman of IXICO Plc (LON:IXI), was set to tell shareholders the company traded strongly last year.
The digital technologies company focused on brain diseases saw increased revenue and reduced operating losses in the year to the end of September.
READ: IXICO expands Assessa PML platform pilot to include pharmacovigilance
“The New Year has started well and we are focused on accelerating the momentum built over the last year,” Spicer’s AGM statement, which was released ahead of the meeting, said.
READ: IXICO reduces losses in year of transition
It was also revealed that Derek Hill, a founder of the company, is stepping down from the board as an executive director and will cease to be an IXICO employee from April 1, though he will maintain a close relationship with IXICO in a scientific capacity.